Abstract
The replacement of destroyed heart valves by mechanical, thrombogenic prostheses would be hard to imagine without the availability of anticoagulant treatment. Coumarins were introduced in clinical practice during and shortly after the Second World War, in the same era that heart valve replacement surgery was pioneered. Still today, vitamin K antagonists are the only available oral anticoagulants for chronic use in patients with mechanical heart valves. Has no progress been made in this field over the past 50 years?

This publication has 10 references indexed in Scilit: